- Home
- ABOS vs MPV Comparison
ABOS vs MPV Comparison
Compare ABOS & MPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABOS | MPV |
|---|---|---|
| Founded | 1996 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 155.7M | 201.1M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABOS | MPV |
|---|---|---|
| Price | $2.65 | $17.61 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.75 | N/A |
| AVG Volume (30 Days) | ★ 578.2K | 12.6K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.71% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.71 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $10.09 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.86 | $15.65 |
| 52 Week High | $3.60 | $21.00 |
Technical Indicators
Market Signals| Indicator | ABOS | MPV |
|---|---|---|
| Relative Strength Index (RSI) | 49.05 | 37.42 |
| Support Level | $1.30 | $15.86 |
| Resistance Level | $3.05 | $19.60 |
| Average True Range (ATR) | 0.26 | 0.78 |
| MACD | -0.06 | -0.14 |
| Stochastic Oscillator | 37.06 | 37.59 |
Price Performance
Historical ComparisonAbout ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.